AU Stock MarketDetailed Quotes
BGT Bio-Gene Technology Ltd
- 0.051
- -0.004-7.27%
20min DelayNot Open Oct 4 15:05 AET
10.27MMarket Cap-3923P/E (Static)
0.051High0.051Low7.00KVolume0.051Open0.055Pre Close357.00Turnover0.08552wk High0.01%Turnover Ratio201.36MShares0.03852wk Low-0.013EPS TTM5.07MFloat Cap0.350Historical HighLossP/E (Static)99.32MShs Float0.038Historical Low-0.013EPS LYR0.00%Amplitude--Dividend TTM3.64P/B1Lot Size--Div YieldTTM
About Bio-Gene Technology Ltd Company
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group’s product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.
Company Profile
SymbolBGT
Company NameBio-Gene Technology Ltd
Founded1995
MarketASX
Fiscal Year Ends06-30
Address400 Collins Street Level 6
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 390681062
Websitehttps://www.bio-gene.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 2, 1 Bligh Street, SYDNEY, NSW, AUSTRALIA, 2000
Company Executives
- Name
- Position
- Salary
- Robert John Klupacs
- Chief Executive Officer & Managing Director,Non-Executive Director,Non-Executive Chairman
- --
- Richard Andrew Jagger
- Chief Executive Officer,Managing Director
- --
- Peter May
- Executive Director
- --
- Christopher Mark Ray
- Non-Executive Director
- --
- Andrew Wallace Guthrie
- Non-Executive Director
- --
- Alex Huong Soo Ding
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data